318 related articles for article (PubMed ID: 25015099)
1. TCF7L2 is a master regulator of insulin production and processing.
Zhou Y; Park SY; Su J; Bailey K; Ottosson-Laakso E; Shcherbina L; Oskolkov N; Zhang E; Thevenin T; Fadista J; Bennet H; Vikman P; Wierup N; Fex M; Rung J; Wollheim C; Nobrega M; Renström E; Groop L; Hansson O
Hum Mol Genet; 2014 Dec; 23(24):6419-31. PubMed ID: 25015099
[TBL] [Abstract][Full Text] [Related]
2. Association of common variants of
Basu J; Mukherjee R; Sahu P; Datta C; Chowdhury S; Mandal D; Ghosh A
Nucleosides Nucleotides Nucleic Acids; 2024; 43(3):185-202. PubMed ID: 37610142
[TBL] [Abstract][Full Text] [Related]
3. Association of type 2 diabetes susceptibility genes (TCF7L2, SLC30A8, PCSK1 and PCSK2) and proinsulin conversion in a Chinese population.
Zheng X; Ren W; Zhang S; Liu J; Li S; Li J; Yang P; He J; Su S; Li P
Mol Biol Rep; 2012 Jan; 39(1):17-23. PubMed ID: 21437630
[TBL] [Abstract][Full Text] [Related]
4. PDX1 and ISL1 differentially coordinate with epigenetic modifications to regulate insulin gene expression in varied glucose concentrations.
Wang W; Shi Q; Guo T; Yang Z; Jia Z; Chen P; Zhou C
Mol Cell Endocrinol; 2016 Jun; 428():38-48. PubMed ID: 26994512
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes.
Lyssenko V; Lupi R; Marchetti P; Del Guerra S; Orho-Melander M; Almgren P; Sjögren M; Ling C; Eriksson KF; Lethagen AL; Mancarella R; Berglund G; Tuomi T; Nilsson P; Del Prato S; Groop L
J Clin Invest; 2007 Aug; 117(8):2155-63. PubMed ID: 17671651
[TBL] [Abstract][Full Text] [Related]
6. Isl1β Overexpression With Key β Cell Transcription Factors Enhances Glucose-Responsive Hepatic Insulin Production and Secretion.
Jung Y; Zhou R; Kato T; Usui JK; Muratani M; Oishi H; Heck MMS; Takahashi S
Endocrinology; 2018 Feb; 159(2):869-882. PubMed ID: 29220426
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in the TCF7L2, CDKAL1 and SLC30A8 genes are associated with impaired proinsulin conversion.
Kirchhoff K; Machicao F; Haupt A; Schäfer SA; Tschritter O; Staiger H; Stefan N; Häring HU; Fritsche A
Diabetologia; 2008 Apr; 51(4):597-601. PubMed ID: 18264689
[TBL] [Abstract][Full Text] [Related]
8. LIM domain-binding 1 maintains the terminally differentiated state of pancreatic β cells.
Ediger BN; Lim HW; Juliana C; Groff DN; Williams LT; Dominguez G; Liu JH; Taylor BL; Walp ER; Kameswaran V; Yang J; Liu C; Hunter CS; Kaestner KH; Naji A; Li C; Sander M; Stein R; Sussel L; Won KJ; May CL; Stoffers DA
J Clin Invest; 2017 Jan; 127(1):215-229. PubMed ID: 27941246
[TBL] [Abstract][Full Text] [Related]
9. Differential transcriptional and posttranslational transcription factor 7-like regulation among nondiabetic individuals and type 2 diabetic patients.
Pradas-Juni M; Nicod N; Fernández-Rebollo E; Gomis R
Mol Endocrinol; 2014 Sep; 28(9):1558-70. PubMed ID: 25058603
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide analysis of PDX1 target genes in human pancreatic progenitors.
Wang X; Sterr M; Burtscher I; Chen S; Hieronimus A; Machicao F; Staiger H; Häring HU; Lederer G; Meitinger T; Cernilogar FM; Schotta G; Irmler M; Beckers J; Hrabě de Angelis M; Ray M; Wright CVE; Bakhti M; Lickert H
Mol Metab; 2018 Mar; 9():57-68. PubMed ID: 29396371
[TBL] [Abstract][Full Text] [Related]
11. TCF7L2 polymorphism, weight loss and proinsulin:insulin ratio in the diabetes prevention program.
McCaffery JM; Jablonski KA; Franks PW; Dagogo-Jack S; Wing RR; Knowler WC; Delahanty L; Dabelea D; Hamman R; Shuldiner AR; Florez JC;
PLoS One; 2011; 6(7):e21518. PubMed ID: 21814547
[TBL] [Abstract][Full Text] [Related]
12. TCF7L2 rs7903146 impairs islet function and morphology in non-diabetic individuals.
Le Bacquer O; Kerr-Conte J; Gargani S; Delalleau N; Huyvaert M; Gmyr V; Froguel P; Neve B; Pattou F
Diabetologia; 2012 Oct; 55(10):2677-2681. PubMed ID: 22911383
[TBL] [Abstract][Full Text] [Related]
13. The LIM homeodomain protein ISL1 mediates the function of TCF7L2 in pancreatic beta cells.
Shao W; Szeto V; Song Z; Tian L; Feng ZP; Nostro MC; Jin T
J Mol Endocrinol; 2018 Jul; 61(1):1-12. PubMed ID: 29678908
[TBL] [Abstract][Full Text] [Related]
14. Polymorphism in the transcription factor 7-like 2 (TCF7L2) gene is associated with impaired proinsulin conversion--A meta-analysis.
Shen J; Fang Y; Ge W
Diabetes Res Clin Pract; 2015 Jul; 109(1):117-23. PubMed ID: 25934528
[TBL] [Abstract][Full Text] [Related]
15. Islet-1 Is essential for pancreatic β-cell function.
Ediger BN; Du A; Liu J; Hunter CS; Walp ER; Schug J; Kaestner KH; Stein R; Stoffers DA; May CL
Diabetes; 2014 Dec; 63(12):4206-17. PubMed ID: 25028525
[TBL] [Abstract][Full Text] [Related]
16. Alterations in TCF7L2 expression define its role as a key regulator of glucose metabolism.
Savic D; Ye H; Aneas I; Park SY; Bell GI; Nobrega MA
Genome Res; 2011 Sep; 21(9):1417-25. PubMed ID: 21673050
[TBL] [Abstract][Full Text] [Related]
17. Genetic origins of low birth weight.
Yaghootkar H; Freathy RM
Curr Opin Clin Nutr Metab Care; 2012 May; 15(3):258-64. PubMed ID: 22406741
[TBL] [Abstract][Full Text] [Related]
18. Loci for insulin processing and secretion provide insight into type 2 diabetes risk.
Broadaway KA; Yin X; Williamson A; Parsons VA; Wilson EP; Moxley AH; Vadlamudi S; Varshney A; Jackson AU; Ahuja V; Bornstein SR; Corbin LJ; Delgado GE; Dwivedi OP; Fernandes Silva L; Frayling TM; Grallert H; Gustafsson S; Hakaste L; Hammar U; Herder C; Herrmann S; Højlund K; Hughes DA; Kleber ME; Lindgren CM; Liu CT; Luan J; Malmberg A; Moissl AP; Morris AP; Perakakis N; Peters A; Petrie JR; Roden M; Schwarz PEH; Sharma S; Silveira A; Strawbridge RJ; Tuomi T; Wood AR; Wu P; Zethelius B; Baldassarre D; Eriksson JG; Fall T; Florez JC; Fritsche A; Gigante B; Hamsten A; Kajantie E; Laakso M; Lahti J; Lawlor DA; Lind L; März W; Meigs JB; Sundström J; Timpson NJ; Wagner R; Walker M; Wareham NJ; Watkins H; Barroso I; O'Rahilly S; Grarup N; Parker SC; Boehnke M; Langenberg C; Wheeler E; Mohlke KL
Am J Hum Genet; 2023 Feb; 110(2):284-299. PubMed ID: 36693378
[TBL] [Abstract][Full Text] [Related]
19. Selective disruption of Tcf7l2 in the pancreatic β cell impairs secretory function and lowers β cell mass.
Mitchell RK; Mondragon A; Chen L; Mcginty JA; French PM; Ferrer J; Thorens B; Hodson DJ; Rutter GA; Da Silva Xavier G
Hum Mol Genet; 2015 Mar; 24(5):1390-9. PubMed ID: 25355422
[TBL] [Abstract][Full Text] [Related]
20. Regulation of insulin synthesis and secretion and pancreatic Beta-cell dysfunction in diabetes.
Fu Z; Gilbert ER; Liu D
Curr Diabetes Rev; 2013 Jan; 9(1):25-53. PubMed ID: 22974359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
